Intranasal Ketamine for Existential Distress in Advanced Cancer. | ClinicLens
Depression and existential distress are highly prevalent among patients with advanced cancer, and there is growing evidence for ketamine as a rapidly acting antidepressant in the population, but few studies have examined existential distress outcomes with ketamine treatment. The
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.